Literature DB >> 23236116

Topical lidocaine to suppress trigemino-cardiac reflex.

K Chigurupati, N N Vemuri, S R Velivela, S S Mastan, A K Thotakura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23236116     DOI: 10.1093/bja/aes450

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  6 in total

Review 1.  Anesthetic influence on occurrence and treatment of the trigemino-cardiac reflex: a systematic literature review.

Authors:  Cyrill Meuwly; Tumul Chowdhury; Nora Sandu; Martin Reck; Paul Erne; Bernhard Schaller
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

2.  Intra-Arterial Lidocaine Blunts the Trigeminocardiac Reflex during Endovascular Treatment of a Carotid-Cavernous Fistula.

Authors:  Renee L Coleman; Dmitri Bezinover; Douglas C Jones; Kevin M Cockroft; Uma R Parekh
Journal:  Case Rep Anesthesiol       Date:  2021-01-05

Review 3.  The Focus and New Progress of Percutaneous Balloon Compression for the Treatment of Trigeminal Neuralgia.

Authors:  Yinghua Xia; Gui Yu; Feixiang Min; Hui Xiang; Jinqing Huang; Jingxing Leng
Journal:  J Pain Res       Date:  2022-09-29       Impact factor: 2.832

4.  Asystole due to stimulation of the supraorbital nerve: abrupt and potentially fatal presentation of the trigeminocardiac reflex.

Authors:  Hyunjee Kim; Dong Gun Lim; Jeong Eon Kim
Journal:  BMJ Case Rep       Date:  2020-08-24

Review 5.  The clinical surrogate definition of the trigeminocardiac reflex: Development of an optimized model according to a PRISMA-compliant systematic review.

Authors:  Cyrill Meuwly; Tumul Chowdhury; Ricardo Gelpi; Paul Erne; Thomas Rosemann; Bernhard Schaller
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Recurrent trigeminocardiac reflex in percutaneous balloon compression for trigeminal neuralgia: A case report.

Authors:  Qin Qin; Yaping Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.